Identification and characterization of a novel non-structural protein of bluetongue virus.
about
Bluetongue Virus NS4 Protein Is an Interferon Antagonist and a Determinant of Virus VirulenceBluetongue viruses based on modified-live vaccine serotype 6 with exchanged outer shell proteins confer full protection in sheep against virulent BTV8Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell ResponsesReassortment between two serologically unrelated bluetongue virus strains is flexible and can involve any genome segmentDisruption of Specific RNA-RNA Interactions in a Double-Stranded RNA Virus Inhibits Genome Packaging and Virus InfectivityFull-genome characterisation of Orungo, Lebombo and Changuinola viruses provides evidence for co-evolution of orbiviruses with their arthropod vectorsCurrent and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations.Epizootic hemorrhagic disease virus induces and benefits from cell stress, autophagy, and apoptosis.Trafficking of bluetongue virus visualized by recovery of tetracysteine-tagged virion particles.Full-Genome Sequencing as a Basis for Molecular Epidemiology Studies of Bluetongue Virus in India.Experimental pathways towards developing a rotavirus reverse genetics system: synthetic full length rotavirus ssRNAs are neither infectious nor translated in permissive cells.Recall T cell responses to bluetongue virus produce a narrowing of the T cell repertoireDual modulation of type I interferon response by bluetongue virus.Virus and host factors affecting the clinical outcome of bluetongue virus infection.Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattleSchmallenberg virus pathogenesis, tropism and interaction with the innate immune system of the host.Evolution of bluetongue virus serotype 1 in northern Australia over 30 yearsFull genome sequencing of Corriparta virus, identifies California mosquito pool virus as a member of the Corriparta virus speciesTransplacental transmission of Bluetongue virus serotype 1 and serotype 8 in sheep: virological and pathological findings.RNA elements in open reading frames of the bluetongue virus genome are essential for virus replicationReal time RT-PCR assays for detection and typing of African horse sickness virusStructure-based identification of functional residues in the nucleoside-2'-O-methylase domain of Bluetongue virus VP4 capping enzyme.Characterising Non-Structural Protein NS4 of African Horse Sickness VirusMultiple genome segments determine virulence of bluetongue virus serotype 8Influence of cellular trafficking pathway on bluetongue virus infection in ovine cellsDuplex Real-Time RT-PCR Assays for the Detection and Typing of Epizootic Haemorrhagic Disease Virus.Widespread Reassortment Shapes the Evolution and Epidemiology of Bluetongue Virus following European Invasion.Development of reverse genetics for Ibaraki virus to produce viable VP6-tagged IBAV.Identification of four novel group-specific bluetongue virus NS3 protein B-cell epitopesIdentification of the Genome Segments of Bluetongue Virus Serotype 26 (Isolate KUW2010/02) that Restrict Replication in a Culicoides sonorensis Cell Line (KC Cells).Non-structural protein NS3/NS3a is required for propagation of bluetongue virus in Culicoides sonorensis.Turnover Rate of NS3 Proteins Modulates Bluetongue Virus Replication Kinetics in a Host-Specific Manner.Development and Evaluation of Real Time RT-PCR Assays for Detection and Typing of Bluetongue Virus.Drosophila melanogaster as a model organism for bluetongue virus replication and tropismComparative analysis of Reoviridae reverse genetics methods.Sensing and control of bluetongue virus infection in epithelial cells via RIG-I and MDA5 helicases.Minimum requirements for bluetongue virus primary replication in vivo.Characterization of a second open reading frame in genome segment 10 of bluetongue virus.Complete Genome Sequences of Five Bluetongue Virus (BTV) Vaccine Strains from a Commercial Live Attenuated Vaccine, a BTV-4 Field Strain from South Africa, and a Reassortant Strain Isolated from Experimentally Vaccinated Cattle.Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes
P2860
Q26700161-9EDD8D7C-7433-4A3D-AE9F-16B82751A9E6Q27319898-E351C9C2-A47E-4298-94EC-B558319A58E6Q27340815-62FA9227-7535-4465-8F8C-8507782503DCQ28392676-9B890231-F725-4544-B799-A574A86284CCQ28551423-52DB9446-F2DA-4D81-B188-F5C5F9A912F8Q28660119-96AFF1F4-9C1A-4703-8591-C746EA62ADD7Q30242080-6EA51EFB-3D88-4F6F-888D-30EF5D3D8FE6Q30557606-A494687C-7F59-40BE-B819-F1742B7182DEQ30603531-C8DCF8E5-70FC-4CFA-A493-428F85994313Q30977460-C633778A-DBE3-4541-A87B-9470AB59046CQ31137956-7FEC834A-5995-42E9-9C4C-EEE73814CB06Q32178442-4AB256FA-8EC5-42D2-9075-2E1A3E555FBCQ34262097-BD724C90-4C4A-47F5-9E38-850ABCDA1867Q34262237-CC737D68-9282-4603-967A-9E67140B4F19Q34347583-E39933F7-BA54-4663-86EA-7A0BFF78291FQ34550761-C0B67BFD-FD5D-47A7-87F2-1F4B976B2103Q34594921-8FD490DC-EA3D-4105-A3FE-123CC3AECD10Q34981260-39860E04-57E2-4197-B4EC-047D366083A4Q35072501-A6F7F451-476C-4A07-80B8-F4737B469111Q35128134-553F888D-2FB3-49B7-B8AF-4A194E09C7AEQ35144932-88D8434D-21B5-4205-BC63-E2017EB25AE6Q35178437-938F2F68-91C8-452F-B96E-665BC72B25FEQ35542582-1D1F06D3-6C1C-430F-A58C-401D274FEB49Q35641548-EE6FC145-231D-400B-B17E-7A11AB0A7776Q35676008-EEFCE636-0CA4-488D-AC93-51A6894964D9Q35687955-7EF6F883-786B-4406-9485-6B5D1DC51E31Q35739703-FEB1255C-A90F-4D04-A3A4-DD92D5599709Q35756880-0C07735B-5461-497E-9BDF-00B6E9B85C7EQ35888832-7025A584-DD1B-4179-88D6-18CAA428EBC9Q35927349-074DAFDC-16DF-4E35-9FC0-3E3BF6A3FD20Q36070650-B6F78D3E-E6C9-4A92-AC57-2663FF95D8FAQ36086306-625A067A-67AF-43E2-BF0A-8EBEE47F1490Q36142591-CD396E21-F22B-4465-A320-6A6995060E69Q36154944-678CB2C9-C594-47EB-9AA4-D2D8E14F120CQ36253330-702BC9CF-CACF-408A-B78B-9B306206A7E1Q36363181-05D8773C-7C6C-4921-8D3C-0EAE17E70E80Q36559484-D581A53A-3416-4BBD-A2A6-E1109C4E4750Q36725550-201CAEC4-0A8B-4D89-93A9-500FE1A75105Q37034279-9A777D0B-22F4-4A42-AA61-EB972F918705Q37174442-70FD3AE7-F9A2-43D3-9531-B2F2FC34DB82
P2860
Identification and characterization of a novel non-structural protein of bluetongue virus.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification and characteriz ...... l protein of bluetongue virus.
@ast
Identification and characteriz ...... l protein of bluetongue virus.
@en
Identification and characteriz ...... l protein of bluetongue virus.
@nl
type
label
Identification and characteriz ...... l protein of bluetongue virus.
@ast
Identification and characteriz ...... l protein of bluetongue virus.
@en
Identification and characteriz ...... l protein of bluetongue virus.
@nl
prefLabel
Identification and characteriz ...... l protein of bluetongue virus.
@ast
Identification and characteriz ...... l protein of bluetongue virus.
@en
Identification and characteriz ...... l protein of bluetongue virus.
@nl
P2093
P2860
P1433
P1476
Identification and characteriz ...... l protein of bluetongue virus.
@en
P2093
Alessia Armezzani
Amr Bayoumy
Andrew Shaw
Frazer Rixon
Giulia Franzoni
Kathryn Allan
Marco Caporale
Matthew Golder
Maxime Ratinier
Sandro Filipe Nunes
P2860
P304
P356
10.1371/JOURNAL.PPAT.1002477
P577
2011-12-29T00:00:00Z